Check out the Bill & Melinda Gates Foundation and LifeArc Grand Challenges request for proposals: "Innovations for Exceptionally Low-Cost Monoclonal Antibody (mAb) Manufacturing." "This Grand Challenge is calling for proposals that offer radical, innovative, and technically feasible pathways to achieving the $10/gram target." Applications are due January 31, 2025. Learn more: https://lnkd.in/g5VfnunT
📢 Calling all innovators! Monoclonal antibodies (mAbs) have enormous potential to transform treatment for infectious diseases like malaria, RSV and HIV. The Gates Foundation and LifeArc just launched a Grand Challenge in search of proposals to make these life-saving therapies more affordable and accessible in low- and middle-income countries. Applications are open now through 31 January 2025. Learn more and apply here: https://bit.ly/3B4JJFv #GrandChallenges